Daiichi Life's A$11.80 per share offer values Challenger at A$8 billion

Daiichi Life's TAL unit made a non-binding indicative offer at A$11.80 per share for 79.5% of Challenger Ltd, valuing the company at approximately A$8 billion and representing a premium to recent trading prices.

The offer represents a 17.7% premium to Challenger's one-month volume weighted average price of A$10.03.

Challenger's Board is considering the indicative offer.

Daiichi Life stated it has made no decision on whether to proceed with a binding transaction.

Daiichi Life offered A$6.3 billion ($4.4 billion) for 79.5% of Challenger Ltd.

The offer values Challenger at about A$8 billion.

Daiichi's TAL Daiichi Life Australia unit offered A$11.80 per share.

Daiichi Life Group subsidiary TAL Daiichi Australia made a non-binding proposal to buy the remaining 79.5% of Challenger's ordinary shares.

The offer price is AU$11.80 per share.

The proposal was made after market close on October 16.

The offer is conditional on due diligence, a scheme implementation agreement on acceptable terms, regulatory approvals, and board recommendation.

Challenger did not disclose a total equity value for the deal.

Reuters estimated the valuation at AU$7.94 billion.

Bloomberg estimated the valuation at AU$7.9 billion.

The offer price represents a 19.8% premium to Friday's close of AU$9.85.

Challenger shareholders do not need to take action in response to the indicative offer.

There is no certainty the proposal will result in a binding offer or transaction.

Challenger's business and market position

Challenger manages A$128 billion in assets.

Challenger provides financial products aimed at retirees.

If the deal proceeds, Daiichi would control an Australian property portfolio valued at A$2.1 billion when Charter Hall took over its management last year.

Challenger first sold its real estate fund management business to Elanor Investors Group for A$38 million in 2023.

That deal moved about A$3.4 billion of Challenger Life and third-party funds across retail, office and industrial assets to Elanor.

In July 2025, Elanor and Challenger agreed to unwind the mandate.

Elanor kept managing the portfolio until 15 October 2025, when it was valued at A$2.1 billion.

The unwind was part of a recapitalisation in which Singapore's Rockworth Capital Partners agreed to invest up to A$125 million in Elanor.

Elanor officially changed its name to Kyron Capital Group earlier this year.

Charter Hall group chief executive David Harrison said his firm would focus on 'implementing strategies to maximise long-term value for this quality core portfolio'.

Challenger was founded in 1985.

Challenger runs Challenger Life, the regulated annuity insurer.

Challenger's funds management arm comprises Challenger Investment Management (fixed income) and Fidante (partners with other managers on equity, fixed income and alternatives).

Challenger is merging Fidante with Channel Capital and will own 45% of the combined business.

Challenger reported normalised profit after tax of A$467.6 million and statutory profit of A$505.6 million in the year ended June.

Challenger said its results were helped by 'positive revaluations on the Australian property portfolio'.

Challenger has not disclosed the current make-up of its portfolio.

Daiichi's stake-building and strategic rationale

Daiichi Life gradually increased its holding in Challenger through two 2025 purchases totaling 19.9% for JPY 103 billion, with the full takeover expected to use nearly half of its JPY 1.5 trillion strategic investment budget for FY2026-FY2030.

The buyout offer came about 18 months after Daiichi began building its stake in Challenger.

Daiichi's TAL unit first moved on Challenger in April 2025.

In April 2025, Daiichi agreed to buy a 15.1% stake from MS&AD Insurance Group for JPY 80 billion ($506 million).

That purchase was a 53% premium to Challenger's share price at the time.

Fiona Macgregor is the chief executive of Daiichi's TAL unit.

Two months after the April 2025 purchase, Daiichi agreed to buy a further 4.8% of Challenger from a fund controlled by Apollo Global Management for about A$247 million.

The two purchases together cost JPY 103 billion for 19.9% of Challenger.

Daiichi expected the holding to add roughly JPY 8 billion to JPY 11 billion to annual earnings.

The Super Members Council forecasts Australia's retirement savings pool will surpass the UK in 2030 and Canada by 2031, making it the world's largest after the US.

In July, Daiichi said it plans about JPY 1.5 trillion in strategic investments between FY2026 and FY2030, with roughly 70% going to developed markets.

The full Challenger buyout, at about JPY 695 billion, would use close to half of that budget, according to a Mingtiandi calculation.

Market reaction and regulatory path

Challenger received the approach after the market closed on 16 October.

Challenger shares surged more than 19% to A$11.75 in Sydney trading on Monday.

Daiichi Life shares gained 1.7% to JPY 1,872 in Tokyo.

Daiichi's two earlier Challenger share purchases required clearance from Australia's Foreign Investment Review Board and the Australian Prudential Regulation Authority.

A full takeover is likely to again require clearances from both agencies.

As of 11:30 am Sydney time on Monday, Challenger's shares rose 17%.

As of recent Tokyo trading, Daiichi Life's shares increased 0.6%.

TAL Daiichi held a 20.19% stake in Challenger as of July 31, per Challenger's fiscal 2026 results published in August.

In April 2025, MS&AD Insurance Group Holdings (TYO:8725) sold its 15.1% stake in Challenger to TAL Daiichi for 80 billion yen.

Two months after the April 2025 transaction (i.e., June 2025), TAL Daiichi acquired an additional 4.8% stake for AU$247 million from AP Liberty GP, controlled by Apollo Global Management.

The proposed acquisition preceded Challenger's fiscal first-quarter results published on Monday.

For the three months ended September 30, Challenger's assets under management increased to AU$31.9 billion from AU$29.5 billion a year prior.

Total sales for the three months ended September 30 rose 52% year-over-year to AU$4.4 billion.

CEO Nick Hamilton attributed the sales growth to demand for guaranteed income products in Australia and Japan.

Challenger is listed on the ASX under ticker CGF.

Daiichi Life Group is listed on the Tokyo Stock Exchange under ticker 8750.

Fiona Macgregor said: "an extension of our commitment to supporting Australians' financial needs in retirement"

David Harrison said: "implementing strategies to maximise long-term value for this quality core portfolio"

Daiichi Life has made no decision on whether to proceed with a binding transaction, and the offer remains conditional on due diligence, regulatory approvals, and board recommendation.